You have 9 free searches left this month | for more free features.

ACUTE MYELOID LEUKEMIA

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti-siglec-6 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 2, 2022

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Oct 24, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial (CD123-CAR-NK cells)

Not yet recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • (no location specified)
Oct 7, 2022

Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

Not yet recruiting
  • Acute Myeloid Leukemia
  • bone marrow aspirate and biopsy
  • (no location specified)
Aug 20, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (8-Chloroadenosine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Acute Myeloid Leukemia Trial (CIML-NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • CIML-NK Cells
  • (no location specified)
Oct 12, 2022

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)

Not yet recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
Apr 19, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • LILRB4 STAR-T cells
  • (no location specified)
Sep 16, 2022

Acute Myeloid Leukemia Trial in Xi'an (infusion of natural killer cells)

Recruiting
  • Acute Myeloid Leukemia
  • infusion of natural killer cells
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 17, 2022

Acute Myeloid Leukemia Trial (with or without venetoclax)

Not yet recruiting
  • Acute Myeloid Leukemia
  • with or without venetoclax
  • (no location specified)
Apr 29, 2022

Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
Feb 15, 2022

Acute Myeloid Leukemia, Relapsed, Adult Trial in Suzhou (CDIAG regimen)

Completed
  • Acute Myeloid Leukemia, Relapsed, Adult
  • CDIAG regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Mar 16, 2022

Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia Trial in United States

Recruiting
  • Relapsed Adult AML
  • +2 more
  • Specialty Palliative Care
  • Primary Palliative Care
  • Boston, Massachusetts
  • +3 more
Aug 12, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Edegem, Roeselare (Venetoclax, 6-mercaptopurine)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Edegem, Antwerp, Belgium
  • +1 more
Aug 16, 2022

Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

Recruiting
  • Acute Myeloid Leukemia
  • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Jun 29, 2022

Healthcare Resource Utilization in Adults Diagnosed With Acute

Completed
  • Acute Myeloid Leukemia (AML)
  • Helsinki, Finland
    Novartis Investigative Site
Aug 3, 2022

Malnutrition And Sarcopenia In Older Acute Myeloid Leukemia

Not yet recruiting
  • Acute Myeloid Leukemia
  • Leukemia, Myeloid
  • Bioelectrical Impedence Analysis Device
  • +4 more
  • (no location specified)
Jul 11, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022